Carnitine and peripheral arterial disease

Annals of the New York Academy of Sciences

Volumn 1033, Issue , 2004, Pages 92-98

  Hiatt, William R ^a,b  

^a Univ of CO Health Sciences Center ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Claudication; Exercise; L carnitine; Peripheral arterial disease (PAD); Propionyl L carnitine

Indexed keywords

ACYLCARNITINE; CARNITINE; PROPIONYLCARNITINE;

ARTERY DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFECT; ELECTRON TRANSPORT; EXERCISE TEST; HUMAN; METABOLIC DISORDER; MUSCLE METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; QUALITY OF LIFE; SKELETAL MUSCLE; TREADMILL EXERCISE; WALKING SPEED;

EID: 10644245703     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1320.008     Document Type: Conference Paper

References (33)

1. CRIQUI, M.H., R.D. LANGER, A. FRONEK et al. 1992. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326: 381-386.
2. DORMANDY, J.A. & R.B. RUTHERFORD. 2000. Management of peripheral arterial disease (PAD): TASC Working Group. J. Vasc. Surg. 31: S1-S296.
3. HIATT, W.R. 2001. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 344: 1608-1621.
4. HIRSCH, A.T., M.H. CRIQUI, D. TREAT-JACOBSON et al. 2004. The Partners Program: a national survey of peripheral arterial disease prevalence, awareness, and ischemic risk. Circulation. In press.
5. CARTER, S.A. 1969. Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA 207: 1869-1874.
6. MCDERMOTT, M.M., P. GREENLAND, K. LIU et al. 2002. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann. Intern. Med. 136: 873-883.
7. ROSE, G.A. & H. BLACKBURN. 1968. Cardiovascular survey methods. WHO Monograph Series No. 56. Geneva.
8. REGENSTEINER, J.G., J.F. STEINER, R.J. PANZER et al. 1990. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J. Vasc. Med. Biol. 2: 142-152.
9. MCDERMOTT, M.M., K. LIU, J.M. GURALNIK et al. 1998. Measurement of walking endurance and walking velocity with questionnaire: validation of the Walking Impairment Questionnaire in men and women with peripheral arterial disease. J. Vasc. Surg. 28: 1072-1081.
10. MCDERMOTT, M.M., S. MEHTA, K. LIU et al. 1999. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J. Gen. Intern. Med. 14: 173-181.
11. HIATT, W.R., D. NAWAZ & E.P. BRASS. 1987. Carnitine metabolism during exercise in patients with peripheral vascular disease. J. Appl. Physiol. 62: 2383-2387.
12. FLANIGAN, D.P., J.P. TULLIS, V.L. STREETER et al. 1977. Multiple subcritical arterial stenoses: effect on poststenotic pressure and flow. Ann. Surg. 186: 663-668.
13. REGENSTEINER, J.G., E.E. WOLFEL, E.P. BRASS et al. 1993. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 87: 413-421.
14. BIEBER, L.L. 1988. Carnitine. Annu. Rev. Biochem. 57: 261-283.
15. BRASS, E.P. & C.L. HOPPEL. 1980. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem. J. 190: 495-504.
16. HIATT, W.R., E.E. WOLFEL, J.G. REGENSTEINER et al. 1992. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J. Appl. Physiol. 73: 346-353.
17. BREVETTI, G., C. ANGELINI, M. ROSA et al. 1991. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation 84: 1490-1495.
18. STEWART, K.J., W.R. HIATT, J.G. REGENSTEINER et al. 2002. Exercise training for claudication. N. Engl. J. Med. 347: 1941-1951.
19. GARDNER, A.W. & E.T. POEHLMAN. 1995. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 274: 975-980.
20. BEEBE, H.G., D.L. DAWSON, B.S. CUTLER et al. 1999. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch. Intern. Med. 159: 2041-2050.
21. MONEY, S.R., J.A. HERD, J.L. ISAACSOHN et al. 1998. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J. Vasc. Surg. 27: 267-274.
22. DAWSON, D.L., B.S. CUTLER, M.H. MEISSNER et al. 1998. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98: 678-686.
23. DAWSON, D.L., B.S. CUTLER, W.R. HIATT et al. 2000. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am. J. Med. 109: 523-530.
24. REGENSTEINER, J.G., J.E. WARE, JR., W.J. MCCARTHY et al. 2002. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J. Am. Geriatr. Soc. 50: 1939-1946.
25. 31P magnetic resonance spectroscopy: a phase II open study. Vasc. Med. 1: 241-245.
26. CIPOLLA, M.J., A. NICOLOFF et al. 1999. Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. J. Vasc. Surg. 29: 1097-1103.
27. BARKER, G.A., S. GREEN, C.D. ASKEW et al. 2001. Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. Med. Sci. Sports Exercise 33: 1415-1422.
28. BREVETTI, G., M. CHIARIELLO, G. FERULANO et al. 1988. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation 77: 767-773.
29. BREVETTI, G., F. DI LISA, S. PERNA et al. 1996. Carnitine-related alterations in patients with intermittent claudication: indication for a focused carnitine therapy. Circulation 93: 1685-1689.
30. BREVETTI, G., S. PERNA, C. SABBA et al. 1992. Superiority of L-propionylcarniline vs. L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study. Eur. Heart J. 13: 251-255.
31. BREVETTI, G., S. PERNA, C. SABBA et al. 1995. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J. Am. Coll. Cardiol. 26: 1411-1416.
32. BREVETTI, G., C. DIEHM & D. LAMBERT. 1999. European multicenter study on propionyl-L-carnitine in intermittent claudication. J. Am. Coll. Cardiol. 34: 1618-1624.
33. HIATT, W.R., J.G. REGENSTEINER, M.A. CREAGER et al. 2001. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am. J. Med. 110: 616-622.